| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2675a41a0b9549145c2135ff642bb3ff |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-265
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B57-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-265
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C327-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02 |
| filingDate |
1992-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e82f6cfcdc07d94ac12b538723be51af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd347ece04b0d6d81bf470ed24d29da3 |
| publicationDate |
1993-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H05105627-A |
| titleOfInvention |
Novel pharmaceutical composition used for treatment of intestinal dysfunction, preparation method thereof, and preparation method of therapeutic drug |
| abstract |
(57) [Summary] (Modified) [Objective] A novel pharmaceutical composition used particularly for the treatment of intestinal dysfunction, a method for preparing the same, and a method for preparing a medicament for the treatment of the above diseases. [Structure] A mixture of [R] amino acid derivative of acetorphan and [S] amino acid derivative, particularly a mixture of enantiomers, wherein the ratio of [R] derivative to [R] + [S] is 65 ± 15% to 20%. A novel pharmaceutical composition applicable to long-term treatment of intestinal irritable syndrome (however, excluding 50% mixture). [R] derivative: [S] derivative: |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017500357-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015522030-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015522031-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H11503470-A |
| priorityDate |
1991-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |